ArticleJournal of experimental & clinical cancer research : CR2025

Genome-wide CRISPR screening identifies PHF8 as an effective therapeutic target for KRAS- or BRAF-mutant colorectal cancers.

Zhao Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.